On Demand - Mid Atlantic Retina/Wills Eye Retina Service Visiting Professor Lecture in Retina - Rishi Singh, MD [Non-CME]

Visiting Professor Lecture - February 2023 - Recorded on February 8, 2023

Featuring Rishi Singh, MD

Dr. Rishi P. Singh MD is a staff surgeon at the Cleveland Clinic Florida, Professor of Ophthalmology at the Lerner College of Medicine, and President of Cleveland Clinic Martin Hospitals in Stuart, FL. He received his bachelors and medical degrees from Boston University and completed his residency at the Massachusetts Eye and Infirmary Harvard Combined Program in Boston, Massachusetts. Dr. Singh then completed a medical and surgical fellowship at the Cole Eye Institute in Cleveland, Ohio.

He specializes in the treatment of medical and surgical retinal disease such as diabetic retinopathy, retinal detachment, and age-related macular degeneration. Dr. Singh has authored more than 200 peer reviewed publications, books, and book chapters and serves as the principal investigator of numerous national clinical trials advancing the treatment of retinal disease. He is the principal investigator at the Center for Ophthalmic Bioinformatics within the Cole Eye Institute at Cleveland Clinic evaluating real world disease data from electronic health records and registries to better understand disease pathogenesis, prognostic outcomes, and treatment efficacy and safety. 

Dr. Singh is the former president on the Retina World Congress and is on the board of the American Society of Retina Specialists.  He is a frequent invited speaker at national and international meeting as well as continuing medical education seminars.  Dr. Singh maintains a strong relationship with drug development and commercial entities by serving on scientific advisory boards.   

Dr. Singh has been honored with several research recognitions such as the Alpha Omega Alpha Research Award, the American Society of Retina Specialists Senior Honor Award, and the American Academy of Ophthalmology Senior Honor Award.

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.